Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases.
Tsoumpra MK, Fukumoto S, Matsumoto T, Takeda S, Wood MJA, Aoki Y. EBioMedicine. 2019 Jul;45:630-645. doi: 10.1016/j.ebiom.2019.06.036. Epub 2019 Jun 27.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642283/
- Home
-
Products and Applications
-
Morpholino Antisense Oligos
- Why Morpholinos?
- Optimal Target Choice
- Methods/Protocols
- Morpholino Products and Properties
- End Modifications and Controls
- Blocking miRNAs
- Blocking Localization Elements of mRNA
- Modify poly-A Tailing
- Other targets: ncRNA, repeat elements, etc.
- External guides for use with RNase P
- Diagnostics
- Uses for Pretargeting & Crosslinking
- Therapeutics
- Bacteria Applications
- Protist Applications
- Insect Applications
-
Morpholino Antisense Oligos
- Ordering
- Customer Support
- Morpholino Publications Database
- FAQ
- About Us
- Contact Us
Add new comment